Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection

Inclusion Criteria: * Patient is 18 to 80 years of age, inclusive. * Patient is scheduled to undergo open bowel resection. * Female patients must be postmenopausal (for at least 1 year), surgically sterile, practicing true sexual abstinence, OR must be using adequate contraception (in the opinion of the investigator) for the duration of the study, including the follow-up period (e.g. contraceptive implants, injectables, oral contraceptives, some intrauterine devices \[IUD\], and/or barrier method (condom or occlusive cap) with spermicidal foam/gel/film/cream/suppository). * Hormonal and IUD methods of contraception must be established for a period of 3 months prior to dosing and, if changed, alternative methods should be used as directed by the investigator throughout the duration of the study. * Females of childbearing potential must have a negative pregnancy test at screening and admission After surgery and prior to administration of the first dose of study drug, the following eligibility criteria must be assessed: * Patient underwent open bowel resection. * Patient has given written informed consent Exclusion Criteria: * Patient weighs more than 200kg (441 pounds). * Patient is classified as American Society of Anesthesiologists (ASA) Class 4, 5, or 6 * Patient has complete bowel obstruction. * Patient is scheduled to receive a low rectal or anal anastomosis (e.g. proctectomy or ileoanal anastomosis) (low rectal is defined as below the anterior peritoneal reflection -…